Cara M. Kenney
Papers
1
Total Citations
8
H-Index
1
About
Dr. Cara M. Kenney is a translational cancer researcher whose work focuses on precision oncology for esophageal cancers, with a particular emphasis on metabolic vulnerabilities and apoptotic signaling. Her most cited study, "Metabolomic and BH3 profiling of esophageal cancers: novel assessment methods for precision therapy" (2018, 8 citations), introduced innovative functional assays to predict treatment response in esophageal cancer patients undergoing neoadjuvant chemoradiotherapy. This work addresses a critical clinical challenge—identifying which patients will achieve a complete pathological response—by combining metabolomic analysis with BH3 profiling to assess mitochondrial apoptotic priming. Dr. Kenney's research bridges the gap between tumor biology and clinical decision-making, offering potential biomarkers to guide therapy selection and avoid unnecessary surgical interventions. Her contributions are particularly impactful given the rising incidence of esophageal cancers and the need for more personalized treatment strategies. By developing novel assessment methods, she has laid groundwork for future studies integrating functional profiling into precision medicine protocols, ultimately aiming to improve survival outcomes and quality of life for patients with this aggressive malignancy.
Research Focus
Key Achievements
Top Papers
- 1